AASLD: Treating Before Transplant Cuts HCV Recurrence (CME/CE)

Courtesy MedPage Today Surgery  Fri, 11/06/2009 - 08:34

BOSTON (MedPage Today) -- In patients with advanced liver disease related to hepatitis C, a course of pegylated interferon and ribavirin (Rebetol) before liver transplant may help them avoid recurrence of infection, a researcher said here.


 

More related items

HIV No Barrier to Liver Transplant
TORONTO (MedPage Today) -- People with HIV do just as well as others after a liver transplant -- as long as they don't have hepatitis C as well, researchers said in Copenhagen.

AASLD: High SVR Rates Seen with Telaprevir for...
BOSTON (MedPage Today) -- Availability of direct antiviral drugs for hepatitis C virus (HCV) infection moved another step closer to realization, with favorable results reported here for...

AASLD: Direct Antivirals Can Beat HCV Without...
BOSTON (MedPage Today) -- The first clinical trial of direct antiviral drugs against hepatitis C virus (HCV) without interferon was a success, researchers said, though the FDA currently won't...

Pedifix Wart Stick Solid-stick Wart Remover Net...
No more embarrassment! Wart STICK 's exclusive formula contains 40% salicylic acid, the #1 doctor-recommended ingredient for wart removal. This unique product delivers the medicine through an...

Ride 'Em Cowgirl! Sex Position Secrets For Better...
Why is this today s best sex position guide? Instead of twisting you into impossible pretzel poses, Dr. Sadie illustrates hundreds of ways to shape your favorite sex positions into a more...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com